As global markets continue to navigate a landscape marked by rising inflation and fluctuating interest rates, U.S. stock indexes are climbing toward record highs, with growth stocks outperforming value shares. In this environment of economic uncertainty and cautious optimism, identifying undervalued stocks can offer investors potential opportunities to capitalize on market inefficiencies while maintaining a focus on fundamentals.
Name | Current Price | Fair Value (Est) | Discount (Est) |
Provident Financial Services (NYSE:PFS) | US$18.65 | US$36.93 | 49.5% |
Tibet Rhodiola Pharmaceutical Holding (SHSE:600211) | CN¥36.50 | CN¥72.75 | 49.8% |
Nuvoton Technology (TWSE:4919) | NT$96.00 | NT$191.23 | 49.8% |
People & Technology (KOSDAQ:A137400) | ₩41600.00 | ₩81998.88 | 49.3% |
Saigon Thuong Tin Commercial Bank (HOSE:STB) | ₫38250.00 | ₫76325.14 | 49.9% |
Kraft Bank (OB:KRAB) | NOK9.10 | NOK18.03 | 49.5% |
Solum (KOSE:A248070) | ₩17660.00 | ₩34915.02 | 49.4% |
Hensoldt (XTRA:HAG) | €40.78 | €81.50 | 50% |
Array Technologies (NasdaqGM:ARRY) | US$6.79 | US$13.53 | 49.8% |
Likewise Group (AIM:LIKE) | £0.185 | £0.37 | 49.8% |
Click here to see the full list of 922 stocks from our Undervalued Stocks Based On Cash Flows screener.
Here's a peek at a few of the choices from the screener.
Overview: Stora Enso Oyj is a Finnish company offering renewable solutions across packaging, biomaterials, wooden constructions, and paper industries globally, with a market cap of €8.61 billion.
Operations: The company's revenue is derived from several key segments: Forest (€2.83 billion), Biomaterials (€1.59 billion), Wood Products (€1.52 billion), Packaging Materials (€4.50 billion), and Packaging Solutions (€987 million).
Estimated Discount To Fair Value: 12.1%
Stora Enso Oyj is trading at €10.92, slightly below its estimated fair value of €12.42, indicating potential undervaluation based on cash flows. Despite a net loss of €136 million for 2024, the company shows promise with expected profitability within three years and revenue growth surpassing the Finnish market average. However, recent impairments totaling €724 million and a low forecasted return on equity (7.4%) present challenges to consider.
Overview: Vimian Group AB operates in the global animal health industry and has a market cap of SEK24.04 billion.
Operations: The company generates revenue from several segments, including Medtech (€123.90 million), Diagnostics (€20.90 million), Specialty Pharma (€172 million), and Veterinary Services (€58.20 million).
Estimated Discount To Fair Value: 23.3%
Vimian Group, trading at SEK45.95, is significantly undervalued based on cash flows with an estimated fair value of SEK59.87. Recent earnings results show a positive turnaround with net income at EUR 12.2 million compared to a loss the previous year. Despite insider selling and low forecasted return on equity (11.1%), Vimian's earnings are expected to grow faster than the Swedish market, supported by strong revenue growth projections of 12.2% annually.
Overview: BayCurrent Consulting, Inc. offers consulting services in Japan with a market capitalization of approximately ¥1.06 trillion.
Operations: BayCurrent Consulting, Inc. generates revenue through its consulting services in Japan.
Estimated Discount To Fair Value: 22.9%
BayCurrent is trading at ¥6,963, about 22.9% below its estimated fair value of ¥9,036.81, indicating it is undervalued based on cash flows. Earnings grew by 21.3% last year and are forecasted to increase by 17.95% annually, outpacing the Japanese market's growth rate of 8.1%. However, recent share price volatility may concern some investors despite strong revenue growth projections of 17.9% per year until Q3 results are announced in January 2025.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Companies discussed in this article include HLSE:STERV OM:VIMIAN and TSE:6532.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.